NANOG-dependent function of TET1 and TET2 in establishment of pluripotency

Nature

Volumn 495, Issue 7441, 2013, Pages 370-374

  Costa, Yael ^a   Ding, Junjun ^b   Theunissen, Thorold W ^a   Faiola, Francesco ^b   Hore, Timothy A ^c   Shliaha, Pavel V ^d   Fidalgo, Miguel ^b   Saunders, Arven ^b   Lawrence, Moyra ^a   Dietmann, Sabine ^a   Das, Satyabrata ^e   Levasseur, Dana N ^e   Li, Zhe ^f   Xu, Mingjiang ^f   Reik, Wolf ^a,c   Silva, José C R ^a   Wang, Jianlong ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF IOWA   (United States)

^f INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; OCTAMER TRANSCRIPTION FACTOR 4; OXYGENASE; TEN ELEVEN TRANSLOCATION 1 PROTEIN; TEN ELEVEN TRANSLOCATION 2 PROTEIN; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

CATALYSIS; CHEMICAL BINDING; ENZYME ACTIVITY; MOLECULAR ANALYSIS; PROTEIN;

ALGORITHM; ANIMAL CELL; ARTICLE; CATALYSIS; CELL LINEAGE; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE LOCUS; GENE SILENCING; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PURIFICATION;

ANIMALS; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOME; HOMEODOMAIN PROTEINS; MICE; NUCLEAR REPROGRAMMING; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS;

EID: 84875370281     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11925     Document Type: Article

References (26)

1. Chambers, I. et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (2003).
2. Mitsui, K. et al. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (2003).
3. Silva, J. et al. Nanog is the gateway to the pluripotent ground state. Cell 138, 722-737 (2009).
4. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
5. Wang, J. et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 444, 364-368 (2006).
6. Kim, J., Cantor, A. B., Orkin, S. H. & Wang, J. Use of in vivo biotinylation to study protein-protein and protein-DNA interactions in mouse embryonic stem cells. Nature Protocols 4, 506-517 (2009).
7. Ding, J., Xu, H., Faiola, F., Ma'ayan, A. & Wang, J. Oct4 links multiple epigenetic pathways to the pluripotency network. Cell Res. 22, 155-167 (2011).
8. Rees, J. S. et al. In vivo analysis of proteomes and interactomes using parallel affinity capture (iPAC) coupled to mass spectrometry. Mol. Cell Proteomics http://dx.doi.org/10.1074/mcp.M110.002386 (2011).
9. Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129-1133 (2010).
10. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
11. Theunissen, T. W. et al. Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr. Biol. 21, 65-71 (2011).
12. Dawlaty, M. M. et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible withembryonic andpostnatal development. Cell StemCell 9,166-175 (2011).
13. Pereira, C. F. & Fisher, A. G. Heterokaryon-based reprogramming for pluripotency. Curr. Protoc. Stem Cell Biol. 9, 4B11-4B114 (2009).
14. Hanna, J. et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601 (2009).
15. Ficz, G. et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398-402 (2011).
16. Doege, C. A. et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488, 652-655 (2012).
17. Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117 (2008).
18. Marson, A. et al.Connecting microRNAgenes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134, 521-533 (2008).
19. Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473, 343-348 (2011).
20. Wu, H. et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473, 389-393 (2011).
21. Das, S., Jena, S. & Levasseur, D. N. Alternative splicing produces Nanog protein variants with different capacities for self-renewal and pluripotency in embryonic stem cells. J. Biol. Chem. 286, 42690-42703 (2011).
22. Yu, M. et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149, 1368-1380 (2012).
23. Kallin, E. M. et al. Tet2 facilitates the derepression of myeloid target genes during CEBPa-induced transdifferentiation of pre-B cells. Mol. Cell 48, 266-276 (2012).
24. Silva, J. et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6, e253 (2008).
25. Wang, J., Levasseur, D. N.&Orkin,S.H.Requirement ofNanog dimerization for stem cell self-renewal and pluripotency. Proc.NatlAcad. Sci.USA 105,6326-6331(2008).
26. Liang, J. et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nature Cell Biol. 10, 731-739 (2008).